How many insider declarations has DeSilva Tara filed?

DeSilva Tara has filed 2 public insider declarations with SEC (Form 4).

What is DeSilva Tara's role?

DeSilva Tara's reported role is not specified by the regulator across the filings.

Which companies does DeSilva Tara report trades for?

DeSilva Tara reports trades for Coeptis Therapeutics Holdings, Inc..

What is DeSilva Tara's declared buy vs sell volume?

Across the available history, declared buys total 238€ and disposals 0.

← Executives ★ Sign in to follow

DT

DeSilva Tara

OFFICER

·SEC (Form 4)

Coeptis Therapeutics Holdings, Inc.

0

申报总数

0

公司

€238

▲ 买入（1 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

1

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

Discover the full record of transactions filed by DeSilva Tara. Director active across 1 company, notably Coeptis Therapeutics Holdings, Inc.. Aggregated, 2 filings have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €238. History available since 12 January 2024. The latest transaction was filed on 11 February 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.

Companies and markets linked to DeSilva Tara

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Coeptis Therapeutics Holdings, Inc. (US)

申报2 总计

◇

DeSilva Tara

Director高管2026年2月11日Coeptis Therapeutics Holdings, Inc.

US$60,19219SEC ↗

5,700 股@ US$10.5699.5% 占其流量Common stockSEC:0001683168-26-001027:0

▲

DeSilva Tara

Director高管2024年1月12日Coeptis Therapeutics Holdings, Inc.

US$26141SEC ↗

466 股@ US$0.56100.0% 占其流量Common StockSEC:0001683168-24-000319:0

标准退出：2024年4月11日 (T+90)

2 条申报中的 2 条

InsidersTradesSigma

← Executives ★ Sign in to follow

DT

DeSilva Tara

OFFICER

·SEC (Form 4)

Coeptis Therapeutics Holdings, Inc.

0

申报总数

0

公司

€238

▲ 买入（1 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

1

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

Discover the full record of transactions filed by DeSilva Tara. Director active across 1 company, notably Coeptis Therapeutics Holdings, Inc.. Aggregated, 2 filings have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €238. History available since 12 January 2024. The latest transaction was filed on 11 February 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.